卵巢黑色素瘤:治疗模式的变化
1Department of Medical Oncology, Institut Curie, Paris, France.
Ocular oncology and pathology
|March 9, 2026
概括
Tebentafusp是一种用于转移性脑膜黑色素瘤 (UM) 的新疗法,可以改善存活率. 针对UM患者的向蛋白激酶C和PMEL17的新疗法也在出现.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 黑色素瘤研究 黑色素瘤研究
背景情况:
- 膜黑色素瘤 (UM) 尽管初级瘤治疗,但转移率很高 (高达50%),导致患者的治疗结果不佳.
- 对转移性UM的有效全身疗法的开发一直是一个重大挑战.
研究的目的:
- 审查目前对转移性阴道膜黑色素瘤治疗的现状.
- 突出新的治疗策略和UM管理中的新兴目标.
主要方法:
- 审查最近的临床试验和治疗疗法批准的毛膜黑色素瘤.
- 分析新兴的向疗法和免疫疗法.
- 讨论生物标志物和组合治疗策略.
主要成果:
- 一种免疫调节双特异融合蛋白Tebentafusp是第一个批准的全身疗法,用于改善HLA A02:01阳性患者转移性UM的整体存活率.
- 循环瘤DNA的减少与更好的生存率有关,并可能作为生物标志物.
- 包括蛋白质激酶C抑制剂 (darovasertib) 和抗体-药物联合体 (DYP688) 在内的替代策略正在为UM进行研究.
结论:
- 对UM的治疗环境正在迅速发展,新的目标和途径正在被确定.
- 在原发性瘤环境中,组合疗法和早期全身治疗对UM患者的改善结果充满希望.
更多相关视频
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
2.2K
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
1.9K
相关概念视频
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K